Actively Recruiting
Evaluating Remote Genetic and Multi-Cancer Early Detection Education to Improve Testing Access Among Black, Latinoa, and Medicaid-enrolled Adults at Risk for Pancreatic Cancer
Led by Brigham and Women's Hospital · Updated on 2026-10-22
80
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a remote approach to support people at higher risk for pancreatic cancer, focusing on Black, Latinoa, and Medicaid-enrolled individuals in Massachusetts who may have had less access to genetic testing and early cancer detection services. This study aims to test whether providing education about genetic testing and multi-cancer early detection MCED testing through online materials alone or combined with a phone call from a trained educator is practical, acceptable, and delivered as planned. Participants will be randomly assigned to receive either only online educational materials or online materials plus a telephone education session from a Pancreatic Cancer Action Network PanCAN educator. After education, participants may choose to have genetic testing using a saliva kit andor MCED testing via blood samples collected at home or a local facility. Positive test results lead to follow-up with specialists at Dana-Farber Cancer Institute, including diagnostic imaging if needed. The study collects data over approximately 6 to 9 months, including surveys and follow-up assessments. Participants complete surveys before and after education, and after testing or declining testing, to measure satisfaction, knowledge, and decision-making. The study tracks completion of genetic and MCED testing, acceptability of education, and adherence to the telephone education content. Safety monitoring includes follow-up for positive MCED results. Participation involves remote activities with some in-person visits only if diagnostic testing is indicated. Enrollment is expected to last about 18 months with a total study completion by March 2029.
CONDITIONS
Brief Title
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
Research Team
T
Tia Kauffman, MPH
J
Jenna Beckwith, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here